Score computed from 21 publicly published third-party lab results. Every input links to its source below.
If you buy through our link or code we may earn a commission. This never affects scores or rank position.
Aavant Research is an unverified PeptideCensus listing. Listed website unreachable at review; profile kept for lookup while the operation's status is unclear. Its 21 published third-party results still appear on our compound boards, marked Unverified.
The Finnrick directory counts 21 published third-party results for Aavant Research, the latest dated 13 Aug 2026. It appears on 7 compound boards; its best scored placement is #3 on the Tirzepatide board, scoring 91 from 15 tests. Freedom Diagnostics' open database holds 1 certificate under its name, the newest dated 27 August 2026.
Whichever seller you use, match the certificate to the lab's own records before trusting a vial: search its code in the Freedom Diagnostics lookup or check a Janoshik report with its key (how to verify a Janoshik report). A certificate covers one tested batch, so compare its batch number and date with the vial you receive.
| Compound | Rank | Score | Tests | Price/mg | Last test |
|---|---|---|---|---|---|
| Glutathione | #3 | — | — | $0.01 | — |
| Tirzepatide | #3 | 91 | 15 | $0.36 | 17 Sept 2026 |
| Wolverine | #4 | — | — | $10.00 | — |
| KPV | #6 | — | — | $0.65 | — |
| Survodutide | #8 | — | — | — | — |
| Mazdutide | #12 | — | — | $2.29 | — |
| NAD+ | #19 | — | — | $0.01 | — |
Every leaderboard placement we track; each row links to the full board and its source record. Rows without scores are rating-level listings the published testing has not yet covered.
| Test date | Certificate | Document |
|---|---|---|
| 27 Aug 2026 | AAVA2608270162 | Open PDF → |
Showing the 1 most recent of 1 certificates this vendor holds in the lab's public database, refreshed daily. Each links to the original PDF on the lab's own servers; reading one is covered in the lookup guide. Viewing certificates here is free and always will be.
Aavant Research posted one of the better tirzepatide records we track, an 89 built on 12 tests at $0.36 per milligram, current to August 2026, within 21 published results overall. At review time its listed website did not resolve, which is the same situation that moved Sunrise Bioresearch to this tier: a testing trail attached to an operation that cannot currently be reached. If the storefront comes back, the case for a ranked listing is straightforward. Until then the record sits here, intact and linked.
Get a heads-up when new tests publish for vendors we track.
Free, unsubscribe anytime. Address is used for the digest and nothing else; see the privacy policy.